Get to know your College: Natalie Walker

In celebration of International Clinical Trials Day (20 May), we’re proud to introduce Natalie Walker, the new Director of the Flinders Clinical Trials Platform at the Flinders Health and Medical Research Institute (FHMRI).

Natalie brings extensive experience in public health, with a strong focus on addiction and harm reduction. She leads a team dedicated to supporting clinical trial activity across the University, helping turn research into real-world impact. Prior to joining Flinders, she was based at the University of Auckland, co-directing major translational health research centres. Also working within the College of Medicine and Public Health, Natalie specialises in pragmatic, community-based trials designed to inform policy and improve health outcomes—particularly for underserved populations. Her work is driven by a passion for equity, prevention, and research that changes lives.

What is your role and what does your work focus on? 

I have two roles at Flinders University. First, I’m the new Director of the Flinders Clinical Trials Platform (formerly known as ‘Health Data and Clinical Trials), within the Flinders Health and Medical Research Institute (FHMRI). Contact us at hdct@flinders.edu.au. This exciting role involves leading an amazing team of academic and professional staff who are experienced in the design and conduct of clinical trials. The team includes Dr Kelly Loffter, Rupali Saikia, Julie Weston, and Mariah Morias, and we’re here to support Flinders University staff and post-graduate students from all colleges to undertake trials. There’s also a great group of trial statisticians and health economists we work alongside.

The other half of my time is spent in the College of Medicine and Public Health. I work across disciplines (e.g., I’ve published in the fields of communicable diseases, cardiovascular disease, cancer, respiratory health, child health, eye health, etc) but have depth in the field of addiction and harm reduction (smoking cessation and vaping cessation, moving into alcohol, cannabis, and methamphetamine). I have undertaken preclinical research through to policy, but I especially like undertaking pragmatic community-based trials (with a strong equity focus) that are designed to inform practice and policy.

Where did you work before joining Flinders? 

I’m a kiwi – and arrived in Adelaide mid-March 2025. I have a public health background and have spent most of my research career at the University of Auckland in New Zealand – specifically within the School of Population Health, Faculty of Medical and Health Sciences.  There I was Co-Director of a Faculty Research Centre called TRANSFORM (the Centre for Translational Health Research: Informing Policy and Practice), as well as Associate Director (and former Director) of the Faculty Centre for Addiction Research.

What inspired you to pursue a career in your current field?

I’m first in family to attend University. I grew up in a small seaside community in New Zealand called Pukerua Bay, where children were free-roaming, and everyone had a vegetable garden. The community was predominately artists, including my grandmother. I credit her with igniting my interest in science as she shone a light on the natural world around me. Because of her I enrolled in University, to undertake a science degree. My career path since then has not been a straight line.  Yes, it’s been guided by supporters (e.g., professors who encouraged me to be fearless) and my insatiable curiosity for knowledge, but it’s also been guided by those saying I had no place in higher education because I’m a woman (yes, I’m from that generation!).  In the end I arrived where I needed to be – disease prevention – a topic I accidently feel into, but a topic close to my heart. Both my grandfathers died from tobacco-related disease, and I’ve had friends and family negatively impacted by addiction. With each clinical trial I undertake there are stories shared by participants about how the research “turned their life around” and made a positive impact not only on their own health, but on that of their families. These messages of success, gratitude and hope keep me moving forward.

Can you share a memorable experience or project from your career that had a significant impact on you or the community?

For many years I have been part of a team researching a medication called cytisine. Cytisine is a plant-based alkaloid and has been used in at least 16 Central/Eastern Europe for more than 50 years as a smoking cessation medication – until very recently cytisine has been relatively unknown (and unavailable) outside of these countries. Cytisine is structurally similar to the world’s most effective smoking cessation mediation, varenicline, but it is much lower cost, has a better side effect profile, and is more acceptable to users. I’ve had the honour to be involved in a large body of research looking at the pharmacokinetics and pharmacodynamics of cytisine, undertaking qualitative research around the acceptability of cytisine to indigenous Māori and Pacific peoples, and four pragmatic clinical trials comparing cytisine to nicotine replacement therapy (N=1,310), varenicline (N= 1,452; N=679), and nicotine vapes (N=804). Each trial has been (or will be) included in the relevant Cochrane systematic reviews, thus informing smoking cessation treatment guidelines around the world. Very recently cystine was finally approved for use in New Zealand and Australia – a decision heavily informed by the cytisine research undertaken in Australasia.  I feel so proud of the team I’ve worked alongside for so many years, to finally get to this point, and to know that the people of NZ and Australia have access (or will very soon have access) to this great smoking cessation medication.  A true example of research informing policy and practice.

How do you like to relax or spend your spare time?

I’m always up for a good ‘road trip’, with some interesting hikes thrown in for fun. I love exploring new and interesting places and spaces, especially when you have good company in the car, some Whittaker’s chocolate, and excellent music to listen to. I’m also a big fan of the arts, architecture, photography, movies, murals, maps, and all things flora and fauna. In winter you’ll likely find me lazing on a couch with a book and a strong coffee. A wild stormy beach is my happy place.  The quiet and vast spaces around the more northern end of Lake Wakatipu, New Zealand come a close second.

Credit: N Walker. Location: Northern end of Lake Wakatipu, New Zealand
Posted in
CMPH Staff Research

Leave a Reply